Find Resources
Best Practices that show evidence of effectiveness in improving public health outcomes when implemented in multiple real-life settings, as indicated by achievement of aims consistent with the objectives of the activities.
RELEASE DATE:
Peer Review Study
This paper analyzes the policy components that contribute to the programmatic success of flu and Tdap pregnancy vaccine programs in three high-income countries, including the United States. Key pillars to increased vaccination coverage include Health Authority accountability, facilitated patient access to vaccination, healthcare professional accountability and engagement, awareness of the burden and severity of diseases, and finally, belief in the benefits of pregnancy vaccination. In the US, given the higher diversity of stakeholders, a multi-stakeholder approach with calls to action from the CDC and endorsement from other scientific societies were key to uptake of vaccinations in pregnancy. It is recommended that maternal task forces reinforce these messages, disseminate toolkits, and that partners address barriers that stand in the way of vaccination, including ensuring that vaccination clinics are convenient for pregnant woman. Successful programs do not require implementation of all components; instead, public health experts should use these as components as guiding tools that can be refined depending on the specificities of the healthcare system in place.
Novel Practices that show potential to achieve desirable public health outcomes in a specific real-life setting and are in the process of generating evidence of effectiveness or may not yet be tested.
RELEASE DATE:
Data Collection Tool
The Coronavirus Perinatal Experiences Impact Survey (COPE-IS) is an assessment tool for new and expecting mothers that was built through a collaborative process with more than 100 scientists and clinicians involved. The tool focuses on experiences of new and expecting mothers, including exposure to COVID-19, financial considerations, social support, restricted activities, and coping.
Novel Practices that show potential to achieve desirable public health outcomes in a specific real-life setting and are in the process of generating evidence of effectiveness or may not yet be tested.
RELEASE DATE:
Peer Review Study
Survey on the impact of COVID-19 on pregnant women that can be adapted to assessing the experiences of this population in future crises. This article discusses the findings of a survey distributed to 1,439 Dutch women who were pregnant between April 4-May 10, 2020. The survey included multiple scales, such as the COVID-19 and Perinatal Experiences scale, the State-Trait Anxiety Inventory, and the Edinburgh Depression Scale, and compared results with a similar survey completed in 2018. The survey included 8 key domain areas, including topics like financial stress, social support, partner support, anxiety symptoms, and depressive symptoms, to name a few. Women reported higher worries related to COVID-19 in general, and also reported higher work/financial related worries. Depression and anxiety also increased, with anxiety rates increasing two-fold.
Emerging Practices that show potential to achieve desirable public health outcomes in a specific real-life setting and produce early results that are consistent with the objectives of the activities and thus indicate effectiveness.
RELEASE DATE:
Peer Review Study
This article presents the results of a non-randomized cohort study comparing opioid agonist therapy (medication assisted treatment [MAT]) for opioid use disorder received via telemedicine, in-person, or a mix of telemedicine and in-person visits. The study was conducted between January 2011 and June 2012 in Ontario, Canada. The telemedicine group had the highest one-year treatment retention rate, followed by the mixed group, and the in-person group had the lowest one-year treatment retention rate. The results suggest telemedicine could be an effective means of increasing access to MAT for opioid use disorder. It should be noted that the study was conducted prior to the COVID-19 pandemic, and replicability will vary based on local resources and MAT regulations.
Promising Practices that show evidence of effectiveness in improving public health outcomes in a specific real-life setting, as indicated by achievement of aims consistent with the objectives of the activities, and are suitable for adaptation by other communities.
RELEASE DATE:
Summary Report/Recommendations
This article focuses on post-pandemic treatment for individuals with substance use disorder. Specifically, this article identifies seven pillars to improve treatment for individuals with substance use disorders in the wake of the COVID-19 pandemic: (1) telemedicine and digital solutions, (2) hospitalization at home, (3) consultation-liaison psychiatric and addiction services, (4) harm-reduction facilities, (5) person-centered care, (6) promote paid work to improve quality of life in people with substance use disorders, and (7) integrated addiction care. The three “best buys” of the World Health Organization (reduce availability, increase prices, and a ban on advertising) are still valid. Additionally, new strategies must be implemented to systematically deal with (a) fake news concerning legal and illegal drugs and (b) controversial scientific information.